JP2013541583A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013541583A5 JP2013541583A5 JP2013537631A JP2013537631A JP2013541583A5 JP 2013541583 A5 JP2013541583 A5 JP 2013541583A5 JP 2013537631 A JP2013537631 A JP 2013537631A JP 2013537631 A JP2013537631 A JP 2013537631A JP 2013541583 A5 JP2013541583 A5 JP 2013541583A5
- Authority
- JP
- Japan
- Prior art keywords
- ibuprofen
- paracetamol
- combination
- composition
- intravenous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (8)
- 痛み又は炎症を鎮めるための静脈投与組成物であって、該組成物が、人に投与するイブプロフェンとパラセタモールの組み合わせを：
ａ）約１２５ｍｇ乃至約１７５ｍｇのイブプロフェンと約４７５ｍｇ乃至約５２５ｍｇのパラセタモールとの組み合わせ；あるいは
ｂ）約２７５ｍｇ乃至約３２５ｍｇのイブプロフェンと約９７５ｍｇ乃至約１，０２５ｍｇのパラセタモールとの組み合わせ；
で有することを特徴とする組成物。 - 約６時間毎に投与されることを特徴とする、請求項１に記載の静脈投与組成物。
- ａ）約１５０ｍｇのイブプロフェンと約５００ｍｇのパラセタモールとの組み合わせ；あるいは
ｂ）約３００ｍｇのイブプロフェンと約１，０００ｍｇのパラセタモールとの組み合わせ；
を含むことを特徴とする請求項１又は２に記載の静脈投与組成物。 - 液剤であることを特徴とする、請求項１、２又は３に記載の静脈投与組成物。
- 人の痛み及び／又は炎症の治療用静脈内薬剤の製造におけるパラセタモールとイブプロフェンの使用であって、該薬剤が一回の投与量あたり：
ａ）約１２５ｍｇ乃至約１７５ｍｇのイブプロフェンと約４７５ｍｇ乃至約５２５ｍｇのパラセタモールとの組み合わせ；あるいは
ｂ）約２７５ｍｇ乃至約３２５ｍｇのイブプロフェンと約９７５ｍｇ乃至約１，０２５ｍｇのパラセタモールとの組み合わせ；
を含むことを特徴とする使用。 - この使用において、該薬剤組成物は、約６時間おきに投与される、請求項５記載の使用。
- 該薬剤組成物が：
ａ）約１５０ｍｇのイブプロフェンと約５００ｍｇのパラセタモールとの組み合わせ；あるいは
ｂ）約３００ｍｇのイブプロフェンと約１，０００ｍｇのパラセタモールとの組み合わせ；
を含むことを特徴とする請求項５又は６記載の使用。 - 該薬剤組成物が液剤であることを特徴とする、請求項５、６又は７記載の使用。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ589011 | 2010-11-04 | ||
| NZ58901110 | 2010-11-04 | ||
| PCT/NZ2011/000226 WO2012060719A1 (en) | 2010-11-04 | 2011-10-26 | A combination composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017055893A Division JP6353577B2 (ja) | 2010-11-04 | 2017-03-22 | 組み合わせ組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013541583A JP2013541583A (ja) | 2013-11-14 |
| JP2013541583A5 true JP2013541583A5 (ja) | 2014-10-09 |
Family
ID=46024668
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537631A Pending JP2013541583A (ja) | 2010-11-04 | 2011-10-26 | 組み合わせ組成物 |
| JP2017055893A Active JP6353577B2 (ja) | 2010-11-04 | 2017-03-22 | 組み合わせ組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017055893A Active JP6353577B2 (ja) | 2010-11-04 | 2017-03-22 | 組み合わせ組成物 |
Country Status (27)
| Country | Link |
|---|---|
| US (5) | US20130225685A1 (ja) |
| EP (1) | EP2635269B1 (ja) |
| JP (2) | JP2013541583A (ja) |
| KR (1) | KR101900520B1 (ja) |
| CN (2) | CN107519159A (ja) |
| AU (1) | AU2011324137B2 (ja) |
| BR (1) | BR112013010829B8 (ja) |
| CA (1) | CA2814057C (ja) |
| CL (1) | CL2013001250A1 (ja) |
| CO (1) | CO6771406A2 (ja) |
| CY (1) | CY1123398T1 (ja) |
| DK (1) | DK2635269T3 (ja) |
| ES (1) | ES2742373T3 (ja) |
| HR (1) | HRP20191489T1 (ja) |
| HU (1) | HUE045442T2 (ja) |
| LT (1) | LT2635269T (ja) |
| MX (2) | MX2013005113A (ja) |
| MY (1) | MY160572A (ja) |
| NZ (1) | NZ609727A (ja) |
| PH (1) | PH12021550804A1 (ja) |
| PL (1) | PL2635269T3 (ja) |
| PT (1) | PT2635269T (ja) |
| RS (1) | RS59258B1 (ja) |
| RU (2) | RU2707089C2 (ja) |
| SG (1) | SG189319A1 (ja) |
| SI (1) | SI2635269T1 (ja) |
| WO (1) | WO2012060719A1 (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013005113A (es) | 2010-11-04 | 2013-06-03 | Aft Pharmaceuticals Ltd | Una composicion combinada. |
| US9072710B2 (en) | 2012-03-16 | 2015-07-07 | Cumberland Pharmaceuticals Inc. | Injectable ibuprofen formulation |
| WO2016008546A1 (en) * | 2014-07-18 | 2016-01-21 | Everbright Pharmaceuticals S.A.R.L. | Aqueous formulation comprising paracetamol and ibuprofen |
| KR20170066549A (ko) * | 2014-10-06 | 2017-06-14 | 큠버랜드 파마슈티컬즈 인코포레이티드 | 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여 |
| WO2018192664A1 (en) | 2017-04-20 | 2018-10-25 | Hyloris Developments Sa | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF |
| EP3651721B1 (en) | 2017-07-10 | 2024-09-04 | Gel Cap Technologies, LLC | Dual release dosage form capsule and methods, devices and systems for making same |
| US11197830B2 (en) * | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
| US11568752B2 (en) * | 2020-01-28 | 2023-01-31 | David Clark Company Incorporated | Gateway retrieval alert device for aircraft pushback operations |
| WO2023281089A2 (en) | 2021-07-08 | 2023-01-12 | Krka, D.D., Novo Mesto | Pharmaceutical composition comprising naproxen and paracetamol |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3990895A (en) * | 1995-12-05 | 1997-06-27 | Adcock Ingram Limited | Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic |
| AU2002224475B2 (en) * | 2001-11-02 | 2008-01-17 | Cumberland Pharmaceuticals Inc. | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| KR101113005B1 (ko) * | 2003-03-21 | 2012-02-24 | 맥네일-피피씨, 인코포레이티드 | 비-스테로이드계 항염증성 약물 투여법 |
| SI1781277T1 (sl) * | 2004-07-07 | 2012-07-31 | Aft Pharmaceuticals Ltd | Kombinirani sestavek ki vsebuje ibuprofen in paracetamol |
| KR20060072839A (ko) * | 2004-12-23 | 2006-06-28 | 김경태 | 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제 |
| US7934627B2 (en) * | 2005-10-13 | 2011-05-03 | Alcoa Inc. | Apparatus and method for high pressure extrusion with molten aluminum |
| EP2089013B1 (en) * | 2006-10-20 | 2017-09-27 | Johnson & Johnson Consumer Inc. | Combination of acetaminophen with ibuprofen for the treament of pain |
| WO2008079818A2 (en) * | 2006-12-21 | 2008-07-03 | Soluprin Pharmaceuticals, Inc. | Intravenous administration of water soluble analgesic formulations |
| US20090264530A1 (en) * | 2008-04-16 | 2009-10-22 | Nickell Robert P | Combined nsaid and acetaminophen formulation and method |
| JP2012505830A (ja) * | 2008-10-14 | 2012-03-08 | エイエフティ ファーマスーティカルズ リミテッド | 医薬品及び医薬品治療 |
| CA2754922C (en) * | 2009-03-12 | 2016-10-18 | Cumberland Pharmaceuticals Inc. | Administration of intravenous ibuprofen |
| WO2012005605A1 (en) * | 2010-07-07 | 2012-01-12 | Aft Pharmaceuticals Limited | A combination composition comprising ibuprofen and paracetamol |
| MX2013005113A (es) | 2010-11-04 | 2013-06-03 | Aft Pharmaceuticals Ltd | Una composicion combinada. |
| KR20170066549A (ko) * | 2014-10-06 | 2017-06-14 | 큠버랜드 파마슈티컬즈 인코포레이티드 | 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여 |
-
2011
- 2011-10-26 MX MX2013005113A patent/MX2013005113A/es not_active Application Discontinuation
- 2011-10-26 JP JP2013537631A patent/JP2013541583A/ja active Pending
- 2011-10-26 BR BR112013010829A patent/BR112013010829B8/pt active IP Right Grant
- 2011-10-26 CN CN201710623266.5A patent/CN107519159A/zh active Pending
- 2011-10-26 WO PCT/NZ2011/000226 patent/WO2012060719A1/en active Application Filing
- 2011-10-26 KR KR1020137014178A patent/KR101900520B1/ko active IP Right Review Request
- 2011-10-26 SG SG2013026265A patent/SG189319A1/en unknown
- 2011-10-26 LT LTEP11838295.1T patent/LT2635269T/lt unknown
- 2011-10-26 NZ NZ609727A patent/NZ609727A/en unknown
- 2011-10-26 EP EP11838295.1A patent/EP2635269B1/en active Active
- 2011-10-26 RU RU2015103107A patent/RU2707089C2/ru active
- 2011-10-26 MX MX2015008709A patent/MX367209B/es unknown
- 2011-10-26 AU AU2011324137A patent/AU2011324137B2/en active Active
- 2011-10-26 ES ES11838295T patent/ES2742373T3/es active Active
- 2011-10-26 DK DK11838295.1T patent/DK2635269T3/da active
- 2011-10-26 PT PT11838295T patent/PT2635269T/pt unknown
- 2011-10-26 HU HUE11838295A patent/HUE045442T2/hu unknown
- 2011-10-26 PL PL11838295T patent/PL2635269T3/pl unknown
- 2011-10-26 CN CN2011800525659A patent/CN103298464A/zh active Pending
- 2011-10-26 MY MYPI2013001237A patent/MY160572A/en unknown
- 2011-10-26 RU RU2013123646/15A patent/RU2013123646A/ru not_active Application Discontinuation
- 2011-10-26 RS RSP20190963 patent/RS59258B1/sr unknown
- 2011-10-26 SI SI201131767T patent/SI2635269T1/sl unknown
- 2011-10-26 US US13/882,953 patent/US20130225685A1/en not_active Abandoned
- 2011-10-26 CA CA2814057A patent/CA2814057C/en active Active
-
2013
- 2013-05-06 CL CL2013001250A patent/CL2013001250A1/es unknown
- 2013-05-22 CO CO13125952A patent/CO6771406A2/es not_active Application Discontinuation
-
2015
- 2015-08-21 US US14/832,154 patent/US20160235695A1/en not_active Abandoned
-
2017
- 2017-03-22 JP JP2017055893A patent/JP6353577B2/ja active Active
-
2018
- 2018-10-01 US US16/149,109 patent/US11446266B2/en active Active
-
2019
- 2019-07-18 CY CY20191100766T patent/CY1123398T1/el unknown
- 2019-08-16 HR HRP20191489 patent/HRP20191489T1/hr unknown
-
2021
- 2021-04-08 PH PH12021550804A patent/PH12021550804A1/en unknown
-
2022
- 2022-09-13 US US17/943,708 patent/US11896567B2/en active Active
-
2024
- 2024-01-05 US US18/405,907 patent/US20240207210A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013541583A5 (ja) | ||
| JP2014528474A5 (ja) | ||
| JP2017506624A5 (ja) | ||
| JP2013155188A5 (ja) | ||
| JP2014530220A5 (ja) | ||
| MX2011013902A (es) | Tratamiento de esclerosis multiple con laquinimod. | |
| JP2012193216A5 (ja) | ||
| PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
| PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| JP2012515184A5 (ja) | ||
| JP2014526503A5 (ja) | ||
| JP2018507243A5 (ja) | ||
| RU2015103107A (ru) | Комбинированная композиция | |
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| JP2013518124A5 (ja) | ||
| JP2016505050A5 (ja) | ||
| JP2012505830A5 (ja) | ||
| JP2011500589A5 (ja) | ||
| JP2010500284A5 (ja) | ||
| JP2017061488A5 (ja) | ||
| NZ604009A (en) | A combination composition comprising ibuprofen and paracetamol | |
| RU2016144695A (ru) | Комплекс танната ситаглиптина | |
| JP2012041314A5 (ja) | ||
| MX2010011193A (es) | Composicion farmaceutica liquida para el tratamiento y prevencion del dolor. | |
| MX2018005298A (es) | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. |